|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hvidovre University Hospital |
|---|---|
| Information provided by: | Hvidovre University Hospital |
| ClinicalTrials.gov Identifier: | NCT00662181 |
Purpose
A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines.
The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.
| Condition |
|---|
|
HIV Infections HIV-Associated Lipodystrophy Syndrome |
| Study Type: | Observational |
| Official Title: | Follow-up on the HIGH: Low Study - the Longterm Effect of Growth Hormone |
| Estimated Enrollment: | 46 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | January 2009 |
| Estimated Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
H, NH
HIV positive patients with and without lipodystrophy
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Participants from the HIGH: low study
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Katrine MH Andersen, stud.med. | 45-36-322-108 | katrine.harries.andersen@hvh.regionh.dk |
| Denmark | |
| Klinisk Forskningscenter, Hvidovre Hospital | |
| Hvidovre, Denmark, 2650 | |
| Principal Investigator: | Ove Andersen, MD | Klinisk Forskningcenter, Hvidovre Hospital |
More Information
| Responsible Party: | Klinisk Forskningscenter, Hvidovre Hospital ( Forskningschef Ove Andersen ) |
| Study ID Numbers: | H-B-2008-053, 2008-41-2145 |
| Study First Received: | April 16, 2008 |
| Last Updated: | April 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00662181 History of Changes |
| Health Authority: | Denmark: Danish Dataprotection Agency; Denmark: The Regional Committee on Biomedical Research Ethics |
|
growth hormone quality of life fat redistribution |
sugar metabolism fat metabolism cytokines |
|
Sexually Transmitted Diseases, Viral Metabolic Diseases Skin Diseases Hormone Antagonists Acquired Immunodeficiency Syndrome Hormones, Hormone Substitutes, and Hormone Antagonists Quality of Life Hormones Immunologic Deficiency Syndromes |
Virus Diseases HIV-Associated Lipodystrophy Syndrome HIV Infections Lipodystrophy Sexually Transmitted Diseases Metabolic Disorder Retroviridae Infections Lipid Metabolism Disorders |
|
Sexually Transmitted Diseases, Viral Slow Virus Diseases Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Infection Hormones Pathologic Processes Syndrome Lipodystrophy Retroviridae Infections RNA Virus Infections Metabolic Diseases Disease |
Immune System Diseases Skin Diseases Acquired Immunodeficiency Syndrome Immunologic Deficiency Syndromes Pharmacologic Actions Virus Diseases HIV-Associated Lipodystrophy Syndrome HIV Infections Skin Diseases, Metabolic Sexually Transmitted Diseases Lentivirus Infections Lipid Metabolism Disorders |
